Domicilium Real Estate Fund III LP bought ELOX
June 10, 2026 · Form 4 insider transaction
Domicilium Real Estate Fund III LP bought 361,578 shares of Eloxx Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
361,578
Price
N/A
Total value
N/A
Role—
Securitycommon stock, $0.01 par value per share
Transaction codeJ: J
Transaction dateJune 10, 2026
Filing dateJune 17, 2026
Shares owned after361,578
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.; The securities are owned directly by BKJLAGG, LLC ("BKJLAGG") and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to BKJLAGG, and (ii) Daniel Simon, the managing member of Domicilium.